Insmed Inc (INSM) Shares Down Despite Recent Market Volatility

1d ago, source: newsheater

The 36-month beta value for INSM is at 0.91. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 as “hold,” and 0 as “sell.” ...

What Makes Insmed (INSM) a Lucrative Investment?

8d ago, source: InvestingChannel on MSN

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter ...

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

22d ago, source: Yahoo Finance

2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it ...

Insmed Stock (NASDAQ:INSM), Analyst Ratings, Price Targets, Predictions

18d ago, source: Benzinga.com

There is no last upgrade for Insmed.

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

1mon ago, source: Nasdaq

BRIDGEWATER, N.J., March 5, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare ...

Validea Detailed Fundamental Analysis - INSM

3d ago, source: Nasdaq

Below is Validea's guru fundamental report for INSMED INC (INSM). Of the 22 guru strategies we follow, INSM rates highest using our Twin Momentum Investor model based on the published strategy of ...

Insmed Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

18d ago, source: Stockhouse

BRIDGEWATER, N.J., April 5, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

22d ago, source: Morningstar

You can also call the Company at 1-844-4-INSMED. Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases.

Insmed Incorporated: Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

13d ago, source:

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases ...